Fifth Third Bancorp
ALT icon

Fifth Third Bancorp’s Altimmune ALT Stock Holding History

Fifth Third Bancorp’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-250
Closed -$903 – 4305
2025
Q4 		$903 Hold
250
– – ﹤0.01% 2518
2025
Q3 		$943 Hold
250
– – ﹤0.01% 2534
2025
Q2 		$968 Hold
250
– – ﹤0.01% 2434
2025
Q1 		$1.25K Hold
250
– – ﹤0.01% 2377
2024
Q4 		$1.8K Hold
250
– – ﹤0.01% 2335
2024
Q3 		$1.53K Hold
250
– – ﹤0.01% 2387
2024
Q2 		$1.66K Hold
250
– – ﹤0.01% 2288
2024
Q1 		$2.54K Hold
250
– – ﹤0.01% 2193
2023
Q4 		$2.81K Hold
250
– – ﹤0.01% 2308
2023
Q3 		$650 Hold
250
– – ﹤0.01% 2494
2023
Q2 		$883 Hold
250
– – ﹤0.01% 2524
2023
Q1 		$1.05K Hold
250
– – ﹤0.01% 2637
2022
Q4 		$4.11K Hold
250
– – ﹤0.01% 2279
2022
Q3 		$3K Hold
250
– – ﹤0.01% 2289
2022
Q2 		$3K Hold
250
– – ﹤0.01% 2328
2022
Q1 		$2K Hold
250
– – ﹤0.01% 2499
2021
Q4 		$2K Hold
250
– – ﹤0.01% 2529
2021
Q3 		$3K Hold
250
– – ﹤0.01% 2313
2021
Q2 		$2K Buy
+250
New +$3.42K ﹤0.01% 2319

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fifth Third Bancorp's ALT Position: Q1 2026 in Review

Fifth Third Bancorp sold out of Altimmune (ALT) in Q1 2026, closing a stake of 250 shares — an estimated $903 sold.

Fifth Third Bancorp first reported a position in ALT in Q2 2021 and held it in 19 quarters. The position peaked at $4.11K in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Fifth Third Bancorp reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • Fifth Third Bancorp sold 250 Altimmune shares in Q1 2026, an estimated $903.
  • Fifth Third Bancorp first reported a position in Altimmune in Q2 2021 and held it in 19 quarters.
  • Fifth Third Bancorp's Altimmune position peaked at $4.11K in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.